EPCAM and neoplasm: To generate tumor cell-selective agents that can degrade Ras, we created modular constructs that contain Ec1 for targeting EpCAM, the Ras-degrading enzyme RRSP as active cargo, and either the translocation domain from DT (RRSP-DT-Ec1) or ETA (Ec1-ETA-RRSP).